HUMA - Humacyte, Inc.
NEXT EARNINGS:
Mar 27, 2026
(in 30 days)
EPS Est: $-0.13
|
Rev Est: $1.3M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$4.17
DETAILS
HIGH:
$6.00
LOW:
$3.00
MEDIAN:
$3.50
CONSENSUS:
$4.17
UPSIDE:
272.32%
Market Cap:
159.96M
Volume:
5,135,565
Avg Volume:
5,255,101
52 Week Range:
0.88-3.94
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.92
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
218
IPO Date:
2020-12-01
EPS (TTM):
-1.26
P/E Ratio:
-4.02
Revenue (TTM):
N/A
Total Assets:
137.87M
Total Debt:
16.54M
Cash & Equiv:
44.94M
Rev Growth (5Y):
-100.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-118.2%
Debt/Equity:
-0.31
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-12 | $-0.14 | $-0.17 | +17.6% | $753000 | $1.3M | -44.2% |
| 2025-08-11 | $-0.24 | $-0.15 | -60.0% | $301000 | $917830 | -67.2% |
| 2025-05-13 | $-0.10 | $-0.19 | +47.4% | $517000 | $764830 | -32.4% |
| 2025-03-28 | $-0.16 | $-0.23 | +30.4% | $7.2M | $640200 | +1029.0% |
| 2024-11-08 | $-0.33 | $-0.26 | -26.9% | — | $214290 | — |
| 2024-08-13 | $-0.27 | $-0.23 | -17.4% | — | — | — |
| 2024-05-10 | $-0.29 | $-0.23 | -26.1% | — | — | — |
| 2024-03-22 | $-0.24 | $-0.25 | +4.0% | $10.8M | $60000 | +17883.3% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1.56M | 1.26M | 1.49M | 6.19M |
| Net Income | (148.70M) | (110.78M) | (11.96M) | (26.48M) | (66.52M) | (85.42M) |
| EPS | -1.26 | -1.07 | -0.12 | -0.66 | -5.52 | -4.25 |
| Total Assets | 137.87M | 128.22M | 204.30M | 286.53M | 106.69M | 168.69M |
| Total Debt | 16.54M | 57.45M | 50.07M | 51.18M | 28.86M | 28.72M |
| Cash & Equivalents | 44.94M | 80.45M | 149.77M | 217.50M | 39.93M | 93.71M |
| Operating Cash Flow | (98.12M) | (73.31M) | (71.13M) | (81.19M) | (55.57M) | (71.79M) |
| Free Cash Flow | (99.69M) | (75.58M) | (72.18M) | (81.41M) | (55.89M) | (79.91M) |
| FCF per Share | -0.84 | -0.73 | -0.70 | -2.04 | -4.49 | -3.97 |
| Book Value | (52.67M) | 13.55M | 116.93M | 122.17M | 70.67M | 132.20M |
| Cash & ST Investments | 44.94M | 80.45M | 151.88M | 225.50M | 39.93M | 93.71M |
| ROC Equity | N/A | -8.18 | -0.10 | -0.22 | -0.94 | -0.65 |